Science Pool

AACR Annual Meeting 2024

Posted by Evotec on Jan 17, 2024 5:01:19 PM

Date: April 05-10

Location: San Diego, CA

Attending: 

  • Itta MacNevin, SVP Business Development
  • John Kamins, SVP Business Development
  • Hajo Schiewe, VP Business Development
  • Nathalie Joly, VP Business Development
  • Michael Esquerre, VP In Vitro Biology
  • Francisco Cruzalegui, SVP In Vitro Biology
  • Pascale Lejeune, SVP Head of Translational Pharmacology
  • Daniel Sommermeyer, Initiative Leader Innovate Oncology
  • Pierre Fons, VP Translational Biomarkers
  • Christoph Schaab, SVP Head of Proteomics & Metabolomics
  • Christophe Boldron, VP Head of Molecular Architects
  • Nizar Serhan, Research Scientist
  • Stephen Durant, VP Scientific Director

 

Evotec will be exhibiting and showcasing their science at the American Association for Cancer Research (AACR) Annual Meeting this April in San Diego, CA.

Join our scientific specialists at booth #1149 and don’t forget to add our poster presentations to your AACR itinerary.

Contact Us to Arrange a Meeting

Poster Presentations  

Development of innovative off-the-shelf cancer immunotherapies with iPSC-derived CD8-positive T-cells

Presenting Author: Daniel Sommermeyer

Date: Sunday, April 7

Time: 1:30- 5:00 PM 

Location: Poster Section 1

Biomarkers analysis on samples from patients in EVT801 clinical trial: Patient characterization and immunomonitoring

Presenting Author: Pierre Fons

Date: Sunday, April 7

Time: 1:30- 5:00 PM 

Location: Poster Section 43

 

Immune checkpoint therapy as a treatment option for non-muscle invasive bladder cancer

Presenting Author: Nizar Serhan

Date: Monday, April 8

Time: 1:30- 5:00 PM 

Location: Poster Section 4

 

EVT801, a novel selective VEGFR-3 inhibitor targeting tumor angiogenesis, is pursuing dose escalation stage of phase I first-in-human study

Presenting Author: Pierre Fons

Date: Monday, April 8

Time: 9:00 AM- 12:30 PM 

Location: Poster Section 49

   

SIRPα knockout iPSC-derived macrophages (iMACs) are resistant to CD47-dependent
inhibition of phagocytosis and efficiently kill tumor cells in pre-clinical models

Presenting Author: Michael Esquerre

Date: Tuesday, April 9

Time: 1:30- 5:00 PM

Location: Poster Section 1

 

If you wish to meet with us in San Diego, get in touch via the form below, we will be happy to arrange a meeting.

 

Learn more about AACR 2024


Tags: Events, Evotec